Radiolabeled Peptides for Cancer Imaging and Therapy: From Bench-to-Bedside
DOI:
https://doi.org/10.2533/chimia.2021.500PMID:
34233812Keywords:
Clinical translation, Exendin-4, Minigastrin, Somatostatin, TheranosticsAbstract
Radiolabeled peptides can deliver radiation selectively to tumors via targeting peptide receptors that are overexpressed on the surface of cancer cells. The radiation is used either for detection (imaging) or for destruction (therapy) of these tumors. The Division of Radiopharmaceutical Chemistry at the University Hospital Basel has conducted pioneering work on the development of peptide-based radiopharmaceuticals. Our research covers the entire spectrum of such developments, from bench-to-bedside, and it is illustrated in this article by selective cases.Downloads
Published
2021-06-30
Issue
Section
Scientific Articles
License
Copyright (c) 2021 Rosalba Mansi, Melpomeni Fani
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
[1]
R. Mansi, M. Fani, Chimia 2021, 75, 500, DOI: 10.2533/chimia.2021.500.